Progressive
Care Inc. Announces Best December in Company History
MIAMI,
FL -- January
15, 2019 -- InvestorsHub NewsWire --
Progressive Care Inc. (OTCQB:
RXMD), a
personalized healthcare services and technology company, today
announced further growth year-over-year in revenue and number of
prescriptions filled for December 2018.
In
December, the company reported a total of $1.7 million in net
revenue, a 6% increase from the same month last year, and a 45%
increase in prescriptions filled during the same month last year,
totaling nearly 28,332 prescriptions filled. This marks the
strongest finish to the year in Company history.
"December was another big month
for us. Progressive Care exceeded December 2017 prescription
fillings and is moving forward on major
initiatives," said S. Parikh Mars, CEO of
Progressive Care. "In December, we finalized the
closing of our first property and are eagerly pushing forward on an
agenda that will capitalize on our many achievements in 2018. We
are confident that 2019 will lead to continued growth, more
record-breaking months, and even bigger milestones while we
continue our high standards for patient service and value-added
healthcare management offerings."
For
more information about Progressive Care, please visit the
company'swebsite.
Connect and stay in touch with
us on social media:
Progressive Care Inc.
https://www.facebook.com/ProgressiveCareUS/
https://twitter.com/ProgressCareUS
PharmCo, LLC
https://www.facebook.com/pharmcorx/
https://twitter.com/PharmCoRx
About Progressive Care Inc.
Progressive Care
Inc. (OTCQB:
RXMD), through its PharmCo, LLC, is a South Florida health
services organization and provider of prescription pharmaceuticals,
compounded medications, provider of tele-pharmacy services, the
sale of anti-retroviral medications, medication therapy management
(MTM), the supply of prescription medications to long-term care
facilities, and health practice risk management.
Cautionary Statement Regarding Forward-Looking Statements
Statements contained herein that are not based upon current or
historical fact are forward-looking in nature and constitute
forward-looking statements within the meaning of Section 27A of the
Securities Act of 1933 and Section 21E of the Securities Exchange
Act of 1934. Such forward-looking statements reflect the
Company's
expectations about its future operating results, performance, and
opportunities that involve substantial risks and uncertainties.
These statements include but are not limited to statements
regarding the intended terms of the offering, closing of the
offering and use of any proceeds from the offering. When used
herein, the words
"anticipate,"
"believe,"
"estimate,"
"upcoming,"
"plan,"
"target,"
"intend"
and
"expect"
and similar expressions, as they relate to Progressive Care Inc.,
its subsidiaries, or its management, are intended to identify such
forward-looking statements. These forward-looking statements are
based on information currently available to the Company and are
subject to a number of risks, uncertainties, and other factors that
could cause the Company's
actual results, performance, prospects, and opportunities to differ
materially from those expressed in, or implied by, these
forward-looking statements.
Investor Relations Contact:
Armen
Karapetyan, Progressive Care
Senior Advisor
Business Development
Armen@progressivecareus.com
www.progressivecareus.com
www.pharmcopharmacy.com
Public Relations Contact:
Kathleen
Gonzales, CMW Media
Kathleen@cmwmedia.com
www.cmwmedia.com
Web and Application Development Contact:
Marcello Jaspan,
Mass Ventures Corp
Marcello@massventurescorp.com
www.massventurescorp.com